A collaborative evaluation of the MS-2 urine screening system indicated that the automated method could successfully identify at least 84% of urine specimens that contained -105 colony-forming units per ml. Most specimens not detected as positive by the system contained primarily diphtheroids and yeasts. Excluding those specimens which contained diphtheroids and yeasts, the MS-2 system correctly identified as positive 94.8% of specimens that contained 2105 colonyforming units per ml and as negative 96.1% of specimens that contained <104 colony-forming units per ml. The automated system is an attractive method for the screening of urine specimens for significant bacteriuria.
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It is generally agreed that a diagnosis of acute urinary tract infection is associated with bacterial counts of -105 colony-forming units (CFU) per ml in at least one voided urine specimen submitted for bacteriological culture (1, 5). Usually, fewer than 20% of such specimens yield colony counts of t105 CFU/ml; hence, clinicians and laboratorians have long sought methods whereby urine specimens with significant bacterial densities could be rapidly identified. Automated methods have recently been developed (3, 4) that allow laboratories to identify for culture processing those urine specimens with significant bacteriuria. One automated system, the MS-2 (Abbott Laboratories, Dallas, Tex.), offers a microbiology laboratory the ability to identify urine specimens with significant bacterial densities (2105 CFU/ml) MS-2 urine screening method. Sealed glass vials (Ampvettes) containing 1.0 ml of sterile eugonic broth were opened with a device provided by the manufacturer. From each well-mixed urine specimen, 0.1 ml was transferred into an Ampvette. From 1 to 11 inoculated vials were placed in a special Ampvette holder, covered with a foam strip, and locked in place by closing the snap lid of the holder unit. Specimen information (e.g., culture accession number or patient name) for each Ampvette tested was then entered through the keyboard of the MS-2 Control Module, and the holder containing the Ampvettes was inserted into one of the eight positions of the MS-2 Analysis Module. The vials were maintained at 35°C and continually agitated throughout the 5-h test period within the Analysis Module. Growth in each Ampvette was measured at 5-min intervals by determining the absorbance at 670 nm. All turbidity measurements were stored in computer memory and were also recorded on magnetic cassette tape, which allowed further graphic analysis of results and evaluation of the computer programs used for data interpretation.
When a continuing increase in turbidity was detected in any Ampvette, the MS-2 defined the positive specimen by immediately printing out an identifying message. Hence, positive specimens were identified throughout the test period, often within the first 1 or 2 h. At the completion of the 5-h test period, the MS-2 printed a summary report for all Ampvettes tested, listing both positive and negative specimens with identifying accession numbers.
RESULTS
In the first phase of testing, a total of 1,649 specimens were evaluated in the two laboratories. Examination of data obtained by conventional methods showed that the distribution of colony counts among the specimens submitted to each laboratory was very similar (Table 1) Twenty-six percent of specimens containing 2103 but <104 CFU/ml and 1.5% of specimens containing <103 CFU/ml were also designated as positive by the MS-2 system in this initial phase of testing.
The high incidence of MS-2 positive results in specimens that contained <104 CFU/ml was of concern both to the investigating laboratories and to the manufacturer. Studies performed at Abbott Laboratories revealed that the foam sealing strip expanded during incubation, resulting in the physical shifting of the Ampvettes within the holder. This occasionally led to false-positive detection induced by the changing position of Ampvettes within the unit. Consequently, an improved material for the sealing strip was developed and implemented.
The second phase of evaluation utilized both the improved sealing strip and a modified MS-2 computer program designed to minimize the number of MS-2 positive results observed with specimens containing <104 CFU/ml. In this second phase, a total of 1,013 midstream urine specimens were tested by conventional and MS-2 methods in both participating laboratories (Table 3). Approximately 84% of the 152 specimens that demonstrated colony counts of -105 CFU/ ml were detected as positive by the MS-2 system. As in the initial testing phase, a majority (18) of the 25 specimens containing 2105 CFU/ ml that were not detected as positive by the MS-2 system contained either diphtheroids or yeasts. The MS-2 system identified 37% of specimens containing _104 but <105 CFU/ml as positive. A lower frequency (15%) of MS-2 positive results was noted with specimens that contained 103 to 104 CFU/ml. Less than 1% of specimens that contained <103 CFU/ml were detected as positive by the MS-2 method.
The elapsed times required to obtain positive MS-2 results in this second phase of testing were examined. As shown in Fig. 1 , almost 50% of positive specimens were detected within the first hour of incubation, 69o within 2 h, 86.5% within 3 h, and 95.2% within 4 h of test initiation.
DISCUSSION
The data presented here indicate that the Abbott MS-2 system is capable of detecting 
